Home/News/Details

U.S. EPA Publishes TSCA Risk Evaluations for Phthalates DBP and DEHP

Jun 16, 2025
USA
TSCA
Favorites
Share
Unlock exclusive content and benefits? Sign up for free today!

On June 4, 2025, the U.S. Environmental Protection Agency (EPA) released the Toxic Substances Control Act (TSCA) risk evaluation drafts and related technical support documents for dibutyl phthalate (DBP) and di(2-ethylhexyl) phthalate (DEHP) for public comment and peer review by the Science Advisory Committee on Chemicals (SACC).

DBP Risk Evaluation Findings

The EPA has preliminarily determined that DBP may pose risks to worker health based on 20 Conditions of Use (COUs), to consumer health based on 4 COUs, and an unreasonable risk to the environment based on 1 COU. For the other 19 COUs of DBP, no risks to human health or the environment were found. For the COUs where worker health risks were identified, these initial risk determinations did not take into account the use of Personal Protective Equipment (PPE). However, the draft risk evaluation indicates that PPE use may reduce exposure and mitigate risks. The EPA found no unreasonable risks to the health of the general population from DBP and no unreasonable risks to human health from cumulative exposure to any of DBP's COUs.

DEHP Risk Evaluation Findings

The EPA's preliminary evaluation indicates that DEHP poses unreasonable risks to worker health based on 13 COUs and to the environment based on 20 COUs. For the remaining COUs of DEHP, no risks to human health or the environment were identified. Similarly, for the COUs where worker health risks were found, the initial risk determinations did not consider PPE use, but PPE use may reduce exposure and mitigate risks. The EPA found no unreasonable risks to the health of the general population from DEHP and no unreasonable risks to human health from cumulative exposure to any of DEHP's COUs.

Relevant Phthalates

DBP and DEHP are part of the five phthalates currently undergoing TSCA risk evaluations. The other three are Butyl Benzyl Phthalate (BBP), Diisobutyl Phthalate (DIBP), and Dicyclohexyl Phthalate (DCHP). In January 2025, the EPA released the draft risk evaluation for DCHP and the draft cumulative risk analysis for all five phthalates, among other documents. It will release the draft risk evaluations for BBP and DIBP to the public in July 2025.

Public Comment and Peer Review

The EPA will accept public comments on the DBP and DEHP risk evaluation drafts in each phthalate's TSCA public docket. The 60 - day comment period ends on August 4, 2025. The EPA will also hold a virtual public SACC meeting from August 4 to 8, 2025, to peer review all documents related to the risk evaluations of the five phthalates.

Next Steps

After considering public comments and the independent expert peer review, the EPA will release the final risk evaluations to determine whether DBP, DEHP, BBP, DIBP, and DCHP pose unreasonable risks to human health or the environment based on the identified COUs.

 

Further Information

EPA

ChemRadar Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: ChemRadar" on this website are copyrighted by ChemRadar. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: ChemRadar" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: ChemRadar" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on ChemRadar raises copyright or other related issues, please contact us within two weeks.

Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline